Literature DB >> 18690921

How vaccine safety can become political--the example of polio in Nigeria.

Christopher J Clements1, Paul Greenough, Diana Shull.   

Abstract

Vaccine safety is increasingly a major aspect of immunization programmes. Parents are becoming more aware of safety issues relating to vaccines their babies might receive. As a consequence, public health initiatives have had to take note of pressures brought to bear by individual parents and groups. Now we document a new phase in vaccine safety where it has been used to achieve political objectives. In 1988, the World Health Assembly declared its intention to eradicate poliomyelitis from the globe by the year 2000. This goal had to be postponed to 2005 for a number of reasons. Although the progress has been spectacular in achieving eradication in almost all nations and areas, the goal has been tantalizingly elusive. But arguably the most difficult country from which to eradicate the virus has been Nigeria. Over the past two years, tension has arisen in the north against immunizing against polio using the oral polio vaccine (OPV). Although this vaccine has been used in every other country in the world including other Muslim states, some religious leaders in the north found reason in August 2003 to advise their followers not to have their children vaccinated with OPV. Subsequent to this boycott, which the Kano governor had endorsed for a year and then ended in July 2004, cases of polio occurred in African nations previously free of the virus, and the DNA finger-print of the virus indicated it had come from Nigeria. In other words, Nigeria became a net exporter of polio virus to its African neighbours and beyond. Now the disease has spread to a dozen formerly polio-free countries, including Sudan and Indonesia. We show that, while the outward manifestations of the northern Nigerian intransigence were that of distrust of vaccine, the underlying problem was actually part of a longstanding dispute about political and religious power vis a vis Abuja. It is unlikely that polio transmission will be interrupted by 2005 if this dispute is allowed to run its course.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18690921     DOI: 10.2174/157488606775252575

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  11 in total

Review 1.  Polio elimination in Nigeria: A review.

Authors:  Usman Nakakana Nasir; Ananda Sankar Bandyopadhyay; Francesca Montagnani; Jacqueline Elaine Akite; Etaluka Blanche Mungu; Ifeanyi Valentine Uche; Ahmed Mohammed Ismaila
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi).

Authors:  Sani-Gwarzo Nasiru; Gambo G Aliyu; Alex Gasasira; Muktar H Aliyu; Mahmud Zubair; Sunusi U Mandawari; Hassana Waziri; Abdulsalami Nasidi; Samer S El-Kamary
Journal:  Pathog Glob Health       Date:  2012-07       Impact factor: 2.894

3.  COVID-19: The Pseudo-Environment and the Need for a Paradigm Change.

Authors:  Richard A Stein; Oana Ometa; Thomas R Broker
Journal:  Germs       Date:  2021-12-29

4.  "They have produced a vaccine, but we doubt if COVID-19 exists": correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria.

Authors:  Zubairu Iliyasu; Amina A Umar; Hadiza M Abdullahi; Aminatu A Kwaku; Taiwo G Amole; Fatimah I Tsiga-Ahmed; Rayyan M Garba; Hamisu M Salihu; Muktar H Aliyu
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

5.  Political will and international collaborative frameworks in infectious diseases.

Authors:  R A Stein
Journal:  Int J Clin Pract       Date:  2015-01       Impact factor: 2.503

6.  COVID-19 vaccine hesitancy in six geopolitical zones in Nigeria: a cross-sectional survey.

Authors:  Babatunde Oluwatosin Ogunbosi; Michael Abel Alao; Olayinka Rasheed Ibrahim; Adaeze Chikaodinaka Ayuk; Rasheedat Mobolaji Ibraheem; Chioma Laura Odimegwu; David Chibuike Ikwuka; Patricia Akintan; OreOluwa Morakinyo; Ayomide Toluwanimi Adeyemi; Ridwan Muhammad Jega; Temitayo Folorunso Olowookere; Olaseinde Emmanuel Bello; Bilkis Iyabo Owolabi; Abejegah Chukwuyem; Lawan Maryah Bukar; Aliu Rasaki; Amudalat Issa; Atana Uket Ewa; Regina Oladokun; Olusegun Olusina Akinyinka
Journal:  Pan Afr Med J       Date:  2022-07-06

7.  Development of a theory-based HPV vaccine promotion comic book for East African adolescents in the US.

Authors:  Isabelle Celentano; Rachel L Winer; Sou Hyun Jang; Anisa Ibrahim; Farah Bille Mohamed; John Lin; Fanaye Amsalu; Ahmed A Ali; Victoria M Taylor; Linda K Ko
Journal:  BMC Public Health       Date:  2021-06-14       Impact factor: 3.295

8.  Determinants of parents' reticence toward vaccination in urban areas in Benin (West Africa).

Authors:  Léonard Fourn; Slim Haddad; Pierre Fournier; Roméo Gansey
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

9.  Coincident polio and Ebola crises expose similar fault lines in the current global health regime.

Authors:  Philippe Calain; Caroline Abu Sa'Da
Journal:  Confl Health       Date:  2015-09-16       Impact factor: 2.723

10.  "We brought our culture here with us": A qualitative study of perceptions of HPV vaccine and vaccine uptake among East African immigrant mothers.

Authors:  Linda K Ko; Victoria M Taylor; Farah Bille Mohamed; H Hoai Do; Fanaye A Gebeyaw; Anisa Ibrahim; Ahmed A Ali; Rachel L Winer
Journal:  Papillomavirus Res       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.